Antipodes Partners
ESTA icon

Antipodes Partners’s Establishment Labs ESTA Stock Holding History

Antipodes Partners’s Portfolio ESTA Stock Details ESTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$565K Buy
8,798
+7,834
+813% +$623K 0.01% 94
2026
Q2 		$82.7K Buy
+964
New +$69.3K ﹤0.01% 107
2026
Q1 		– Sell
-969
Closed -$70.6K – 134
2025
Q4 		$70.6K Sell
969
-338
-26% -$20.4K ﹤0.01% 97
2025
Q3 		$53.6K Sell
1,307
-741
-36% -$30.3K ﹤0.01% 93
2025
Q2 		$87.5K Buy
2,048
+73
+4% +$2.55K ﹤0.01% 77
2025
Q1 		$80.6K Buy
+1,975
New +$73.6K ﹤0.01% 77

Other funds holding ESTA

JW Asset Management
JW Asset Management Miami Beach, Florida $240M AUM 83.9% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Antipodes Partners's ESTA Position: Q3 2026 in Review

Antipodes Partners increased its Establishment Labs (ESTA) stake by 813% in Q3 2026, buying an estimated $623K and bringing the position to 8,798 shares worth $565K. The position accounts for 0.01% of the portfolio, ranked #94.

Antipodes Partners first reported a position in ESTA in Q1 2025 and has held it in 6 quarters since. 79 funds tracked by Wall St. Rank hold ESTA as of Q3 2026.

  • Antipodes Partners held 8,798 shares of Establishment Labs worth $565K as of Q3 2026.
  • Antipodes Partners bought 7,834 Establishment Labs shares in Q3 2026, an estimated $623K.
  • Establishment Labs made up 0.01% of Antipodes Partners's portfolio in Q3 2026, its #94 holding.
  • Antipodes Partners first reported a position in Establishment Labs in Q1 2025 and has held it in 6 quarters since.
  • 79 funds tracked by Wall St. Rank held Establishment Labs as of Q3 2026.

Based on Antipodes Partners's 13F filing for Q3 2026, filed 5 Nov 2026.